Péter Buzder-Lantos

Title: Innovations of Peter Buzder-Lantos

Introduction

Peter Buzder-Lantos is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target the CXCR3 receptor. With a total of 8 patents to his name, his work is focused on addressing diseases caused by abnormal activation of chemokines.

Latest Patents

His latest patents include "Substituted B-amino acid derivatives as CXCR3 receptor antagonists." This invention relates to compounds that are useful for the preventive and therapeutic treatment of diseases linked to CXCR3 chemokines. The patent also details a process for preparing these compounds, along with pharmaceutical compositions and novel intermediates used in their preparation. Another significant patent is "Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists," which similarly addresses the treatment of diseases caused by abnormal activation of CXCR3 chemokines.

Career Highlights

Peter Buzder-Lantos is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Peter has collaborated with talented individuals such as Imre Bata and Veronika Bartane Bodor. These collaborations have enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Peter Buzder-Lantos is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly improve therapeutic options for patients. His contributions to the field are marked by his innovative patents and collaborations with other experts.